Q4 2024 Conmed Corp Earnings Call Transcript
Key Points
- Conmed Corp (CNMD) reported a year-over-year increase in total sales of 5.8% for the fourth quarter and 5% for the full year, demonstrating consistent growth.
- The General Surgery business showed strong performance with constant currency growth of 8.7% in Q4 and 7.5% for the full year.
- AirSeal experienced strong double-digit growth, with record capital and disposable sales, indicating robust demand.
- Adjusted net income for the fourth quarter increased by 26.2% year-over-year, and adjusted diluted net earnings per share rose by 26.4%.
- The company improved its adjusted gross margin by 120 basis points in Q4 and 110 basis points for the full year, reflecting better product mix and operating leverage.
- The Orthopedic business faced supply challenges, resulting in below-market performance with only 2.4% growth in Q4 and 2.5% for the full year.
- Despite improvements, the overall sales growth in 2024 was below the potential of Conmed Corp (CNMD)'s portfolio.
- The company is facing potential tariff impacts from international trade negotiations, which could affect future financial performance.
- Conmed Corp (CNMD) experienced a decrease in cash balance from $38.5 million in September to $24.5 million at year-end.
- The company is dealing with a currency headwind that is expected to impact gross margins and adjusted EPS in 2025.
Thank you for standing by, and welcome to CONMED's Fourth Quarter Fiscal Year 2024 Earnings Conference Call. (Operator Instructions)
Before the conference call begins, let me remind you that during this call, management will be making comments and statements regarding its financial outlook, its plans and objectives. These statements represent the forward-looking statements that involve risks and uncertainties, as those terms are defined under the federal securities laws.
Investors are cautioned that any such forward-looking statements are not guarantees of future events, performance or results. The company's actual results may differ materially from its current expectations. Please refer to the risks and other uncertainties disclosed under the forward-looking information in today's press release as well as the company's SEC filings for more details on the risks and uncertainties that may cause actual results to differ materially. The company disclaims any obligation to update any forward-looking statements that may be discussed during the call, except as may be required by applicable law
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
